Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis

American Journal of Kidney Diseases

Volumn 44, Issue 3, 2004, Pages 509-516

  McMahon, Lawrence P ^a   Chester, Kate ^a   Walker, Rowan G ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

concentration; darbepoetin alfa; Dialysis membrane; enoxaparin; erythropoietin alfa; high flux; iron sucrose; low flux; low molecular weight heparin

Indexed keywords

BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; SUCROSE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS; HUMAN; MALE; PERMEABILITY; PROTEIN ANALYSIS;

ADULT; AGED; ENOXAPARIN; EPOETIN ALFA; ERYTHROPOIETIN; FEMALE; FERRIC COMPOUNDS; HEMATOLOGIC AGENTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 4444350001     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.05.036     Document Type: Article

References (14)

1. K.R. Polkinghorne, L.P. McMahon, G.J. Becker Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients Am J Kidney Dis 40 2002 990 995
2. M. Moia, G. Graziani, P.M. Tenconi, I. Martinelli, C. Ponticelli Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patients Ann Ital Med Intern 12 1997 67 71
3. M.J. Garcia Cortes, M.C. Sanchez Perales, A. Liebana Beneficial effect of AN69 membranes on anemia in hemodialyzed patients Nefrologia 21 2001 370 375
4. M.P. Kooistra, S. Kersting, I. Gosriwatana Non-transferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion Eur J Clin Invest 32 suppl 1 2002 S36 S41
5. F. Locatelli, L. Del Vecchio, S. Andrulli Dialysis Its role in optimizing recombinant erythropoietin treatment Nephrol Dial Transplant 16 suppl 7 2001 S29 S35
6. M. Allon, K. Kleinman, M. Walczyk Pharmacokinetics and pharmacodynamics of darbepoetin alfa and epoetin in patients undergoing dialysis Clin Pharmacol Ther 72 2002 546 555
7. I.C. Macdougall, D.E. Roberts, I. Cahill, G.A. Coles, J.D. Williams Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis Lancet 1 8635 1989 425 427
8. J. Petersen, M.S. Kang, M.T. Hays Erythropoietin can be administered during dialysis A kinetic analysis ASAIO J 42 1996 27 33
9. K. Opatrny Jr, A. Krouzecky, J. Wirth, L. Vit, J. Eiselt The effects of a polyacrylonitrile membrane and a membrane made of regenerated cellulose on the plasma concentrations of erythropoietin during hemodialysis Artif Organs 22 1998 816 820
10. H. Mori, K. Hiraoka, R. Yorifuji Adsorption of human recombinant erythropoietin on dialysis membranes in vitro Artif Organs 18 1994 725 728
11. A.K. Cheung, M. Hohnholt, J.K. Leypoldt, M. DeSpain Hemodialysis membrane biocompatibility The case of erythropoietin Blood Purif 9 1991 153 163
12. A. Besarab, J.W. Kaiser, S. Frinak A study of parenteral iron regimens in hemodialysis patients Am J Kidney Dis 34 1999 21 28
13. G. Chandler, J. Harchowal, I.C. Macdougall Intravenous iron sucrose Establishing a safe dose Am J Kidney Dis 38 2001 988 991
14. J. Yee, A. Besarab Iron sucrose The oldest iron therapy becomes new Am J Kidney Dis 40 2002 1111 1121